Brief: Nemaura Medical Scales-Up Pilot Expansion of proBEAT
27/06/2023 14:43
June 27 (Reuters) - Nemaura Medical Inc NMRD.O :
* NEMAURA MEDICAL - ANNOUNCES NEXT COMMERCIALIZATION STAGE
OF ITS
PROBEAT SENSOR AND AI-BASED FEEDBACK PLATFORM, AUGMENTING BEAT
DIABETES PROGRAM
* NEMAURA MEDICAL INC - PILOTS ARE INTENDED AS A PRECURSOR
TO
REVENUE GENERATING CONTRACTS FOR PROBEAT AND WILL COMMENCE OVER
COMING WEEKS AND MONTHS
* NEMAURA MEDICAL - CONTINUING DISCUSSIONS WITH
CORPORATIONS,
HEALTH INSURERS IN U.S. TO INCREASE NUMBER OF PILOTS THAT WILL
RUN IN CALENDAR YEAR 2023
Source text for Eikon: ID:nGNX5Sw1L1
Further company coverage: NMRD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nemaura Medical
See all newsBrief: Nemaura Medical To Move To OTC Markets
U.S. RESEARCH ROUNDUP- Ameren Corp, Bread Financial Holdings, Exelon Corp
Brief: Nemaura Medical Receives Positive Nasdaq Listing Decision
Brief: Nemaura Medical Secures $10 Mln Non-Dilutive Credit Facility
Brief: Nemaura Launches Direct To Consumer Offering Of Metabolic Health Program